FABP3 and angina pectoris: We previously found independent associations between a high level of FABP3 with plasma visfatin, high-sensitivity CRP, and white blood cell count, suggesting that the role of FABP3 in the pathophysiology of reduced ejection fraction in patients with stable angina may be through inflammatory processes (21).